ALBEMARLE CORP (ALB) earnings date, results and what the price requires
NYSE · SEC CIK 0000915913 · SEC filings checked Oct 16, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 5, 2026 | $1.74B | $480.0M | $3.52 | Filing |
| Mar 31, 2026 | May 6, 2026 | $1.43B | $319.1M | $2.34 | Filing |
| Dec 31, 2025 | Feb 11, 2026 | $1.43B | $-414.2M | $-3.88 | Filing |
| Sep 30, 2025 | Nov 5, 2025 | $1.31B | $-160.7M | $-1.72 | Filing |
| Jun 30, 2025 | Jul 30, 2025 | $1.33B | $22.9M | $-0.16 | Filing |
| Mar 31, 2025 | Apr 30, 2025 | $1.08B | $41.3M | $0.00 | Filing |
| Dec 31, 2024 | Feb 12, 2025 | $1.23B | $75.3M | $0.29 | Filing |
| Sep 30, 2024 | Nov 6, 2024 | $1.35B | $-1.07B | $-9.45 | Filing |
What would ALBEMARLE CORP have to report for its valuation to change?
At $98.18, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 100.3% a year, to $8.39. On that path the next quarter needs diluted EPS near $-3.45, against $-1.72 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 100.3% | 100.3% |
| EPS needed in final year | $8.39 | $8.39 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. ALB goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.